Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to -0.16%.

  • IDEAYA Biosciences' Return on Capital Employed rose 5.00% to -0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.16%, marking a year-over-year increase of 5.00%. This contributed to the annual value of -0.39% for FY2024, which is 12.00% down from last year.
  • Latest data reveals that IDEAYA Biosciences reported Return on Capital Employed of -0.16% as of Q3 2025, which was up 44.51% from -0.29% recorded in Q4 2024.
  • IDEAYA Biosciences' 5-year Return on Capital Employed high stood at -0.10% for Q2 2021, and its period low was -0.29% during Q4 2024.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.21% (2024), whereas its average is -0.22%.
  • As far as peak fluctuations go, IDEAYA Biosciences' Return on Capital Employed decreased by 13bps in 2022, and later increased by 5bps in 2025.
  • IDEAYA Biosciences' Return on Capital Employed (Quarterly) stood at -0.15% in 2021, then declined by 2bps to -0.17% in 2022, then declined by 7bps to -0.24% in 2023, then decreased by 5bps to -0.29% in 2024, then rose by 5bps to -0.16% in 2025.
  • Its Return on Capital Employed was -0.16% in Q3 2025, compared to -0.29% in Q4 2024 and -0.21% in Q3 2024.